Valuations in healthcare technology can vary widely based on revenue mix, customer mix, specific niche and state of consolidation within a particular segment of the market. However, healthtech valuations are bolstered by strong public market performance and ongoing waves of M&A in the sector. Companies with solutions that integrate the continuum of care are seeing high demand and thus higher valuations.